Strides Pharma receives USFDA approval for anti-inflammatory drug
Strides Pharma Science on Wednesday announced that its step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for Ibuprofen oral suspension USP, 100 mg/5 mL (OTC) from the United States Food & Drug Administration.The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Children's Motrin oral suspension, 100 mg/mL, of Johnson & Johnson Consumer Inc. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain from various conditions such as headache, dental pain, muscle aches. It is also used to redu...